Hochvolumige Antikörper-Testplattform könnte die Forschungs- und Behandlungsentwicklung von Krankheiten beschleunigen

„More than 150 different FDA-approved antibody therapeutics are being used in clinical settings to treat diseases from cancer to infectious disease to autoimmune diseases. With a rapid, high-throughput method like ours, if we can search for a potential antibody candidate that’s really good against a certain disease, then it has great potential in becoming an effective therapeutic,“ said graduate student Wenhao „Owen“ Ouyang, the first author of the study.